Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients

To evaluate the pharmacokinetic effect of adding delavirdine mesylate to the antiretroviral regimens of human immunodeficiency virus (HIV)-infected patients stabilized on a full dosage of ritonavir (600 mg every 12 h), 12 HIV-1-infected subjects had delavirdine mesylate (400 mg every 8 h) added to t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shelton, Mark J., Hewitt, Ross G., Adams, John, Della-Coletta, Andrew, Cox, Steven, Morse, Gene D.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2003
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC153300/
https://ncbi.nlm.nih.gov/pubmed/12709342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.5.1694-1699.2003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars